Share

Clinically Relevant Resistance in Cancer Chemotherapy

2012-12-06 Medical
Download Clinically Relevant Resistance in Cancer Chemotherapy PDF Online Free

Author :
Release : 2012-12-06
Genre : Medical
Kind : eBook
Book Rating : 739/5 ( reviews)

GET EBOOK


Book Synopsis Clinically Relevant Resistance in Cancer Chemotherapy by : Borje Andersson

Download or read book Clinically Relevant Resistance in Cancer Chemotherapy written by Borje Andersson. This book was released on 2012-12-06. Available in PDF, EPUB and Kindle. Book excerpt: Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long term remission rates in several important tumor types. These include childhood leukemia, adult leukemias and lymphomas, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as "drug resistance". This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge.

Multi-Drug Resistance in Cancer

2012-08-09 Medical
Download Multi-Drug Resistance in Cancer PDF Online Free

Author :
Release : 2012-08-09
Genre : Medical
Kind : eBook
Book Rating : 647/5 ( reviews)

GET EBOOK


Book Synopsis Multi-Drug Resistance in Cancer by : Jun Zhou

Download or read book Multi-Drug Resistance in Cancer written by Jun Zhou. This book was released on 2012-08-09. Available in PDF, EPUB and Kindle. Book excerpt: Chemotherapy is one of the major treatment options for cancer patients; however, the efficacy of chemotherapeutic management of cancer is severely limited by multidrug resistance, in that cancer cells become simultaneously resistant to many structurally and mechanistically unrelated drugs. In the past three decades, a number of mechanisms by which cancer cells acquire multidrug resistance have been discovered. In addition, the development of agents or strategies to overcome resistance has been the subject of intense study. This book contains comprehensive and up-to-date reviews of multidrug resistance mechanisms, from over-expression of ATP-binding cassette drug transporters such as P-glycoprotein, multidrug resistance-associated proteins, and breast cancer resistance p- tein to the drug ratio-dependent antagonism and the paradigm of cancer stem cells. The book also includes strategies to overcome multidrug resistance, from the development of compounds that inhibit drug transporter function to the modulation of transporter expression. In addition, this book contains techniques for the detection and imaging of drug transporters, methods for the investigation of drug resistance in animal models, and strategies to evaluate the efficacy of resistance reversal agents. The book intends to provide a state-of-the-art collection of reviews and methods for both basic and clinician investigators who are interested in cancer multidrug resistance mechanisms and reversal strategies. Tianjin, China Jun Zhou v Contents Preface. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v Contributors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix 1 Multidrug Resistance in Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Bruce C. Baguley 2 Multidrug Resistance in Oncology and Beyond: From Imaging of Drug Efflux Pumps to Cellular Drug Targets . . . . . . . . . . . . . . . . . . . . . . . . . .

Molecular and Clinical Advances in Anticancer Drug Resistance

2012-12-06 Medical
Download Molecular and Clinical Advances in Anticancer Drug Resistance PDF Online Free

Author :
Release : 2012-12-06
Genre : Medical
Kind : eBook
Book Rating : 726/5 ( reviews)

GET EBOOK


Book Synopsis Molecular and Clinical Advances in Anticancer Drug Resistance by : Robert F. Ozols

Download or read book Molecular and Clinical Advances in Anticancer Drug Resistance written by Robert F. Ozols. This book was released on 2012-12-06. Available in PDF, EPUB and Kindle. Book excerpt: The importance of drug resistance in cancer chemotherapy cannot be over stated. The 500,000 patients who die every year from cancer in the United States have, in most cases, been treated with chemotherapy. Many of these patients responded initially to chemotherapy, but death resulted from the development of drug-resistant tumors. In the first volume in the series. Drug Resistance in Chemotherapy the results of comprehensive laboratory studies aimed at understanding the mechanisms for resistance to individual agents and to the development of broad cross-resistance were described. In the past 2 years there has been substantial progress in understanding the molecular biology associated with these mechanisms of drug resistance. For the first time we are starting to understand which mechanisms are playing an im portant role in human tumors, and even more importantly, clinical trials have recently been initiated in an effort to reverse specific forms of drug resistance. The purpose of this volume is to describe the new advances, both at the molecular level and in the clinic regarding mechanisms of drug resistance and potential ways this resistance can be circumvented. This volume is focused upon mechanisms of resistance associated with two major classes of anticancer drugs: alkylating agents (including cisplatin) and the natural products (e. g. , adriamycin and vinblastine). The first section of the book describes new insights into the genetic mechanisms associated with drug resistance.

Multiple Drug Resistance in Cancer 2

2013-04-17 Medical
Download Multiple Drug Resistance in Cancer 2 PDF Online Free

Author :
Release : 2013-04-17
Genre : Medical
Kind : eBook
Book Rating : 745/5 ( reviews)

GET EBOOK


Book Synopsis Multiple Drug Resistance in Cancer 2 by : Martin Clynes

Download or read book Multiple Drug Resistance in Cancer 2 written by Martin Clynes. This book was released on 2013-04-17. Available in PDF, EPUB and Kindle. Book excerpt: Resistance to chemotherapy, and especially multi-drug resistance, represents a significant barrier to the successful treatment of cancer. This multi-author volume brings together a wide range of up-to-date reviews on different aspects of our knowledge of drug-resistance mechanisms, written by experts in the different areas. Particular attention is paid to recently discovered mechanisms relating to oncogene expression and in particular to proteins involved in regulation and execution of apoptosis. Other important topics covered include DNA repair, topoisomerases, cell cycle control, oxygenation and vascularisation of tumours, LRP, intermediate filament proteins and low-level resistance. Recent developments in understanding the role of efflux pumps (P-170, MRP) in multi-drug resistance are also reviewed. This book will be useful to clinicians and scientists working in the areas of chemotherapy, drug resistance, DNA repair and apoptosis research.

Cytotoxic Drug Resistance Mechanisms

2008-02-01 Medical
Download Cytotoxic Drug Resistance Mechanisms PDF Online Free

Author :
Release : 2008-02-01
Genre : Medical
Kind : eBook
Book Rating : 878/5 ( reviews)

GET EBOOK


Book Synopsis Cytotoxic Drug Resistance Mechanisms by : Robert Brown

Download or read book Cytotoxic Drug Resistance Mechanisms written by Robert Brown. This book was released on 2008-02-01. Available in PDF, EPUB and Kindle. Book excerpt: There is now a range of cytotoxic drugs that have considerable clinical usefulness in producing responses in tumors and even, in a small proportion of cases, cure. However, the acquisition of drug resistance is a major clinical problem and is perhaps the main limiting factor in successful treatment of cancer. Thus, a tumor initially sensitive to chemotherapy will, in the majority of cases, eventually recur as a resistant tumor, which will then progress. Much of our understanding of drug resistance mechanisms comes from the study of tumor cell lines grown in tissue culture. We now understand many of the - lecular mechanisms that can lead to a cell acquiring resistance to antic- cer drugs; however, we still do not know which mechanism(s) are those most relevant to the problem of clinical drug resistance. Indeed, given that many of the cytotoxic anticancer drugs were discovered by random screening, it is - clear what features give a clinically useful anticancer drug a sufficient the- peutic index to be of value. The aim of Cytotoxic Drug Resistance Mechanisms is to provide pro- cols that are appropriate for examining the mechanisms of cellular resistance to anticancer cytotoxics in human tumor samples. Tumor cell lines have been enormously useful as experimental models of drug resistance mechanisms, however they have limitations and we need to address the relevance of such mechanisms in patients’ tumors. Examining drug resistance in tumors is much more problematic than in cell lines.

You may also like...